Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Bioorg Med Chem. 2018 May 1;26(8):2186-2197. doi: 10.1016/j.bmc.2018.03.024. Epub 2018 Mar 15.
Pin1 (Protein interacting with NIMA1) is a cis-trans isomerase and promotes the amide bond rotation of phosphoSer/Thr-Pro motifs in its substrates. Inhibition of Pin1 might be a novel strategy for developing anticancer agents. Herein, a series of pyrimidine derivatives were synthesized and their Pin1 inhibitory activities were evaluated. Among them, four compounds (2a, 2f, 2h and 2l) displayed potent inhibitory activities against Pin1 with IC values lower than 3 µM. This series of pyrimidine-based inhibitors presented time-dependent inhibition against Pin1. The structure-activity relationships on the 2-, 4- and 5-positions of the pyrimidine ring were analyzed in details, which would facilitate further exploration of new Pin1 inhibitors.
Pin1(与 NIMA1 相互作用的蛋白)是一种顺反异构酶,可促进其底物中磷酸丝氨酸/苏氨酸 - 脯氨酸基序的酰胺键旋转。抑制 Pin1 可能是开发抗癌药物的一种新策略。本文合成了一系列嘧啶衍生物,并对其 Pin1 抑制活性进行了评价。其中,有四个化合物(2a、2f、2h 和 2l)对 Pin1 表现出较强的抑制活性,IC 值低于 3 µM。这一系列嘧啶类抑制剂对 Pin1 呈现时间依赖性抑制。详细分析了嘧啶环的 2-、4-和 5-位的构效关系,这将有助于进一步探索新的 Pin1 抑制剂。